Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Antiviral Research|July 18, 2006
Herpesvirus latency and therapy--from a veterinary perspectiveHugh J Field, Subhajit Biswas, Islam T MohammadAntiviral Chemistry & Chemotherapy|July 10, 2008
Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutationsSubhajit Biswas, Hugh J FieldDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 25, 2010
Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virusHugh J Field, Subhajit BiswasAntiviral Chemistry & Chemotherapy|March 16, 2007
High frequency of spontaneous helicase-primase inhibitor (BAY 57-1293) drug-resistant variants in certain laboratory isolates of HSV-1Subhajit Biswas, Mihaiela Swift, Hugh J FieldThe Journal of Antimicrobial Chemotherapy|June 7, 2007
Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1Subhajit Biswas, Christopher Smith, Hugh J FieldFuture Medicinal Chemistry|December 24, 2013
Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infectionsSubhajit Biswas, Soumi Sukla, Hugh J FieldAntiviral Research|December 19, 2006
The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1Subhajit Biswas, Lyn Jennens, Hugh J FieldThe Journal of General Virology|May 1, 2009
A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structureSubhajit Biswas, Ricardo Núñez Miguel, Soumi Sukla, et al.Antiviral Research|June 10, 2008
Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicitySubhajit Biswas, Laurence S Tiley, Holger Zimmermann, et al.The Journal of Antimicrobial Chemotherapy|May 11, 2010
Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitorSoumi Sukla, Subhajit Biswas, Alexander Birkmann, et al.Pageof 10